Neurim Pharmaceuticals Ltd
Hadar Elovitch is a Clinical Trial Manager with a background in clinical project management, CRA, clinical nutrition, and study coordination. With experience in companies such as Neurim Pharmaceuticals, VBL Therapeutics, ICON Strategic Solutions, and GCP Clinical Studies, Hadar has a solid foundation in the pharmaceutical industry. Education includes a Bachelor of Science in Clinical Nutrition from The Hebrew University of Jerusalem, supplemented by a CRA course at Bioforum Company.
Neurim Pharmaceuticals Ltd
Neurim Pharmaceuticals is a neuroscience drug discovery and development company creating drugs for brain restoration & reinforcement, focusing on the central nervous system. With a proven track record of drug development and commercialization, Neurim’s first products, Circadin® and Slenyto® , are already in use in more than 40 countries across 5 continents. Constantly expanding into additional therapeutic areas, the R&D pipeline comprises new products that address insomnia, Alzheimer’s dementia and sleep apnea.